Carvas AO, Leuthardt A, Kulka P, Lommi G, Hassan S, Coester B, Lundh S, Pers T, Secher A, Raun K, Lutz TA, Le Foll C
Precautions: For healthcare professional use
This Isnt Just a Petition, Its a Public Record The nonprofit officially submitted all 27,000+ signatures and 400+ comments in formal letters to the FDA and the USPTO, asking for: To the FDA requesting an action from the following: Allow regulated compounding when no affordable alternative exists Fast-track generic GLP-1 approvals Advocate for insurance coverage Pressure big pharma to lower prices To the USPTO , requesting they address the impact of evergreening patents that extend exclusivity and limit market competition
& Stratakis, C
As Big Tech companies like Amazon expand deeper into healthcare, and as venture capital and private equity increasingly back telehealth platforms acquiring or partnering with compounding pharmacies, the power dynamics are starting to evolve
This strict rule makes skilled legal representation particularly crucial in Raleigh and across the state